Scandinavian Biopharma is expanding by hiring a PhD in cell- and molecular biology

We are happy to announce that Teresa Holmlund has joined us. Teresa has a PhD in cell and molecular biology and ten years of academic research experience studying molecular mechanisms in mitochondrial disease, cancer and severe congenital neutropenia.

– It feels great to be a part of Scandinavian Biopharma. It’s really motivating to work with the development of a new vaccine that can contribute to improved public health.

The expansion is a part of the company’s continued success and we are delighted to have Teresa on board.




Go to MyNewsdesk

We are a research-based specialty biopharma company determined to give people worldwide a longer and better life.